Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 10;41(4):646-648.
doi: 10.1016/j.ccell.2023.03.003.

Adoptive cell transfer immunotherapy for patients with solid epithelial cancers

Steven A Rosenberg  1 , Maria R Parkhurst  2 , Paul F Robbins  2
Affiliations

Adoptive cell transfer immunotherapy for patients with solid epithelial cancers

Steven A Rosenberg et al. Cancer Cell. .

Abstract

Efforts to apply adoptive cell transfer (ACT) immunotherapy to patients with common epithelial cancers have been stimulated by the demonstration that the majority of these patients contain lymphocytes reactive against the expressed products of their cancer mutations. Early efforts to specifically target these antigens have been promising.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, et al. (1988). Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 319, 1676–1680. 10.1056/NEJM198812223192527. - DOI - PubMed
    1. Seitter SJ, Sherry RM, Yang JC, Robbins PF, Shindorf ML, Copeland AR, McGowan CT, Epstein M, Shelton TE, Langhan MM, et al. (2021). Impact of prior treatment on the Efficacy of adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma. Clin. Cancer Res. 27, 5289–5298. 10.1158/1078-0432.CCR-21-1171. - DOI - PMC - PubMed
    1. Rohaan MW, Borch TH, van den Berg JH, Met O, Kessels R, Geukes Foppen MH, Stoltenberg Granhøj J, Nuijen B, Nijenhuis C, Jedema I, et al. (2022). Tumor-infiltrating lymphocyte therapy or ipilimumab in Advanced melanoma. N. Engl. J. Med. 387, 2113–2125. 10.1056/NEJMoa2210233. - DOI - PubMed
    1. Krishna S, Lowery FJ, Copeland AR, Bahadiroglu E, Mukherjee R, Jia L, Anibal JT, Sachs A, Adebola SO, Gurusamy D, et al. (2020). Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328–1334. 10.1126/science.abb9847. - DOI - PMC - PubMed
    1. Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, et al. (2013). Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747–752. - PMC - PubMed

Substances